Concepedia

Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy

Soili Saarelainen, Antti Taivainen, Marja Rytkönen‐Nissinen, Seppo Auriola, Anu K. Immonen, R. Mäntyjärvi, J. Mikko Rautiainen, Tuure Kinnunen, Tuomas Virtanen

Clinical & Experimental Allergy · 2004 · 58 citations · 23 references

DOI

Abstract

The recombinant allergens can be used reliably to identify Can f 1 and Can f 2-sensitized individuals. However, the two allergens are insufficient as reagents for diagnosing dog allergy.

References

23

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC

Richard Beasley · The Lancet · 1998 · 3.4K citations

, , +9

Position Paper: Allergen standardization and skin tests

Sten Dreborg, Anthony J. Frew · Allergy · 1993 · 748 citations · Full text

, , +4

Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System<sup>™</sup>

Robert Movérare, Lena Elfman, Erkki Vesterinen et al. · Allergy · 2002 · 162 citations

The major dog allergens, <i>Can f</i> 1 and <i>Can f</i> 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant forms

Adam Konieczny, Jay P. Morgenstern, Christine B. Bizinkauskas et al. · Immunology · 1997 · 144 citations · Full text

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

Tanja Ball, Wolfgang R. Sperr, Peter Valent et al. · European Journal of Immunology · 1999 · 141 citations · Full text